Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren?s contracture and Peyronie?s disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.
|Shares Outstanding||EPS||1.63||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||111.07%||Sales Growth - Q/Q||20.56%||P/E||29.54|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||17.95%||ROE||18.48%||ROI|
|Current Ratio||31.82||Quick Ratio||Long Term Debt/Equity||Debt Ratio||0.03|
|Gross Margin||Operating Margin||55.74%||Net Profit Margin||36.77%||Dividend Payout Ratio|
|Cash From Financing Activities||1.08 M||Cash From Investing Activities||-2.15 M||Cash From Operating Activities||1.99 M||Gross Profit|
|Net Profit||2.33 M||Operating Profit||3.56 M||Total Assets||34.67 M||Total Current Assets||28.99 M|
|Total Current Liabilities||910 K||Total Debt||Total Liabilities||1000 K||Total Revenue||5.61 M|
|High 52 week||71.62||Low 52 week||49.72||Last close||49.91||Last change||0.14%|
|RSI||15.08||Average true range||1.91||Beta||0.4||Volume||22.66 K|
|Simple moving average 20 days||-7.28%||Simple moving average 50 days||-10.22%||Simple moving average 200 days||-19.18%|
|Performance Week||-2.29%||Performance Month||-14.44%||Performance Quart||-20.02%||Performance Half||-24.95%|
|Performance Year||-15.05%||Performance Year-to-date||-17.64%||Volatility daily||1.2%||Volatility weekly||2.69%|
|Volatility monthly||5.52%||Volatility yearly||19.12%||Relative Volume||155.17%||Average Volume||48.38 K|
|New High||3.64%||New Low|
2020-05-11 08:05:00 | BioSpecifics Reports First Quarter 2020 Financial and Operating Results
2020-05-11 08:00:00 | BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer
2020-04-29 11:30:03 | Is BioSpecifics Technologies BSTC Stock Outpacing Its Medical Peers This Year?
2020-04-23 11:33:03 | New Strong Buy Stocks for April 23rd
2020-04-20 09:17:01 | 5 Stocks With Rising Cash Flows to Battle Coronavirus Crisis
2020-04-16 07:27:11 | Check These 7 Top-Ranked Stocks With Solid Net Profit Margins
2020-04-15 10:19:02 | New Strong Buy Stocks for April 15th
2020-04-10 16:00:00 | BioSpecifics Adopts Replacement Stockholder Rights Plan
2020-04-10 11:30:03 | Is BioSpecifics Technologies BSTC Outperforming Other Medical Stocks This Year?
2020-04-09 08:05:00 | BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors
2020-04-09 08:00:00 | BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
2020-04-07 12:00:04 | BioSpecifics BSTC Upgraded to Strong Buy: Here's Why
2020-04-02 10:22:02 | Yes, You Can Time the Market. Find out How - April 02, 2020
2020-03-30 13:52:05 | These Stocks Are Potentially Undervalued
2020-03-16 16:01:00 | BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
2020-03-03 09:00:28 | These 3 Biotech Stocks Are Outperforming Their Peers — Here's Why
2020-02-20 06:34:25 | Does The BioSpecifics Technologies Corp. NASDAQ:BSTC Share Price Fall With The Market?
2020-02-14 05:00:00 | Small Cap Play on Collagenase-Based Therapies
2020-02-05 09:23:02 | When Does Market Timing Actually Work? - February 05, 2020
2020-01-21 05:56:58 | Do BioSpecifics Technologies's NASDAQ:BSTC Earnings Warrant Your Attention?
2020-01-17 09:34:02 | How to Time the Markets Like an Investing Pro - January 17, 2020
2019-12-24 09:37:02 | The Market Timing Secrets No One Talks About - December 24, 2019
2019-12-22 08:15:37 | Calculating The Fair Value Of BioSpecifics Technologies Corp. NASDAQ:BSTC
2019-12-13 12:38:10 | Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp. BSTC
2019-12-04 08:36:01 | Simple Market Timing Strategies That Work - December 04, 2019
2019-11-22 07:11:21 | Here's How P/E Ratios Can Help Us Understand BioSpecifics Technologies Corp. NASDAQ:BSTC
2019-11-14 08:53:01 | The Truth About Market Timing - November 14, 2019
2019-11-08 09:25:02 | BioSpecifics Technologies BSTC Q3 Earnings and Revenues Beat Estimates
2019-11-08 08:01:00 | BioSpecifics Reports Third Quarter 2019 Financial and Operating Results
2019-11-01 10:30:02 | BioSpecifics Technologies BSTC to Report Q3 Results: Wall Street Expects Earnings Growth
2019-10-31 14:20:34 | Here’s What Hedge Funds Think About BioSpecifics Technologies Corp. BSTC
2019-10-24 09:00:01 | The Truth About Market Timing - October 24, 2019
2019-10-21 07:17:13 | Is BioSpecifics Technologies Corp.'s NASDAQ:BSTC 20% ROE Better Than Average?
2019-10-17 09:00:01 | BioSpecifics BSTC Upgraded to Buy: Here's Why
2019-10-10 08:01:00 | BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer
2019-10-03 08:49:12 | When Does Market Timing Actually Work? - October 03, 2019
2019-09-25 14:38:57 | Have Insiders Been Selling BioSpecifics Technologies Corp. NASDAQ:BSTC Shares?
2019-09-13 08:39:12 | The Truth About Market Timing - September 13, 2019
2019-09-10 04:56:08 | Endo Files BLA for CCH With the FDA for Cellulite Candidate Revised
2019-09-09 09:50:01 | Endo International Files BLA for Label Expansion of Xiaflex
2019-08-26 08:37:12 | Yes, You Can Time the Market. Find out How - August 26, 2019